Showing results 1 to 20 of 357
next >
| Issue Date | Title | Author(s) |
| 2013 | 2 ',3 '-Cyclic Nucleotide 3 '-Phosphodiesterases Inhibit Hepatitis B Virus Replication | Ma, Hui; Zhao, Xing-Liang; Wang, Xue-Yan; Xie, Xing-Wang; Han, Jin-Chao; Guan, Wen-Li; Wang, Qin; Zhu, Lin; Pan, Xiao-Ben; Wei, Lai |
| 2015 | Abnormal CD4+T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection | Kong, Fanyun; Zhang, Wei; Feng, Bo; Zhang, Henghui; Rao, Huiying; Wang, Jianghua; Cong, Xu; Wei, Lai |
| 2017 | Abnormal phenotypic features of IgM plus B cell subsets in patients with chronic hepatitis C virus infection | Kong, Fanyun; Feng, Bo; Zhang, Henghui; Rao, Huiying; Wang, Jianghua; Cong, Xu; Wei, Lai |
| 2015 | Absolute quantification of serum microRNA-122 and its correlation with liver inflammation grade and serum alanine aminotransferase in chronic hepatitis C patients | Wang, Jiang-hua; Jiang, Dong; Rao, Hui-yng; Zhao, Jing-min; Wang, Yu; Wei, Lai |
| 2019 | ACTIVATION OF THE IL11-ERK SIGNALING PATHWAY IN CD163(+) MACROPHAGE PROMOTES NONALCOHOLIC FATTY LIVER DISEASE DEVELOPMENT IN MICE AND HUMAN | Wang, Xiaoxiao; Rao, Huiying; Li, Xiaohe; Wu, Nan; Huang, Rui, Jr.; Fei, Ran; Liu, Feng; Wei, Lai |
| Jul-2022 | Addressing the heterogeneity of fibrosis in liver biopsy specimens with qFibrosis - a new paradigm for an old problem | Kleiner, David E.; Chang, Pik Eu Jason; Tai, Dean; Chng, Elaine; Ren, Yayun; Liu, Feng; Rao, Huiying; Wei, Lai; Sanyal, Arun |
| Jul-2021 | AI digital pathology using qFibrosis reveals heterogeneity of fibrosis regression in hepatitis B and C patients with SVR | Liu, Feng; Sun, Yameng; Tai, Dean; Ren, Yayun; Chng, Elaine; Wee, Aileen; Bedossa, Pierre; Huang, Rui; Wang, Jian; Wei, Lai; You, Hong; Rao, Huiying |
| 8-Jun-2020 | Al diffusion at AlN/Si interface and its suppression through substrate nitridation | Wei, Lai; Yang, Xuelin; Shen, Jianfei; Liu, Danshuo; Cai, Zidong; Ma, Cheng; He, Xiaoguang; Tang, Jun; Qi, Shengli; Xu, Fujun; Wang, Xinqiang; Ge, Weikun; Shen, Bo |
| 2019 | Alcohol consumption analysis among patients with liver disease in China | Xie, Yan-Di; Zhao, Chang-Qing; Wang, Jiu-Ping; Cheng, Chang-Sheng; Zhou, Jun-Ying; Zhang, Ying; Xia, Hong; Wei, Lai |
| 2023 | Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China | Hua, Rui; Kong, Fei; Li, Guangming; Wen, Xiaofeng; Zhang, Yuexin; Yang, Xingxiang; Meng, Chenxin; Xie, Wen; Jiang, Yongfang; Wang, Xiaozhong; Han, Xueji; Huang, Yan; Mao, Qing; Wang, Jiefei; Guan, Yujuan; Chen, Jiayu; Ma, Yingjie; Xiong, Qingfang; Ma, Hong; Yan, Xuebing; Rao, Huiying; Zhao, Yingren; Sun, Tong; Zhu, Liying; Mao, Xiaorong; Lian, Jianqi; Deng, Guojiong; Xin, Yongning; Wang, Yifei; Ye, Yinong; Xu, Bin; Gao, Hainv; Tan, Youwen; Li, Dongliang; Yang, Dongliang; Su, Minghua; Zhang, Xiaomeng; Min, Jie; Shi, Xinsheng; Wei, Lai; Niu, Junqi |
| 2019 | All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china | Wei, Lai; Xu, Xiaoyuan; Guan, Yujuan; Zheng, Sujun; Sheng, Ji-Fang; Yang, Xingxiang; Ma, Yuanji; Huang, Yan; Kang, Yi; Wen, Xiaofeng; Li, Jun; Tan, Youwen; He, Qing; Xie, Qing; Wang, Maorong; An, Ping; Gong, Guozhong; Liu, Huimin; Ning, Qin; Hua, Rui; Ning, Bo; Xie, Wen; Zhang, Jiming; Huang, Wenxiang; Yang, Yongfeng; Lin, Minghua; Zhao, Yingren; Yu, Yanhong; Jia, Ji-Dong; Yang, Dongliang; Chen, Liang; Ye, Yinong; Nan, Yuemin; Gong, Zuojong; Zhang, Quan; Hu, Peng; Wang, Fu-Sheng; Li, Yongguo; Li, Dongliang; Jia, Zhansheng; Hou, Jinlin; Chen, Chengwei; Wu, Jinzi |
| Nov-2020 | AMAP RISK SCORE PREDICTS HEPATOCELLULAR CARCINOMA DEVELOPMENT IN CHRONIC HEPATITIS PATIENTS: AN INTERNATIONAL COHORT COLLABORATION | Fan, Rong; Papatheodoridis, George; Sun, Jian; Innes, Hamish; Toyoda, Hidenori; Xie, Qing; Mo, Shuyuan; Sypsa, Vana; Guha, Indra Neil; Kumada, Takashi; Niu, Junqi; Dalekos, George; Yasuda, Satoshi; Barnes, Eleanor; Lian, Jianqi; Suri, Vithika; Idilman, Ramazan; Barclay, Stephen T.; Dou, Xiaoguang; Berg, Thomas; Hayes, Peter C.; Flaherty, John F.; Zhou, Yuanping; Zhang, Zhengang; Buti Ferret, Maria Asuncion; Hutchinson, Sharon J.; Guo, Yabing; Luis Calleja, Jose; Lin, Lanjia; Zhao, Longfeng; Chen, Yongpeng; Janssen, Harry L. A.; Zhu, Chaonan; Shi, Lei; Tang, Xiaoping; Gaggar, Anuj; Wei, Lai; Jia, Ji Dong; Irving, William L.; Johnson, Philip; Lampertico, Pietro; Hou, JinLin |
| Dec-2020 | aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis | Fan, Rong; Papatheodoridis, George; Sun, Jian; Innes, Hamish; Toyoda, Hidenori; Xie, Qing; Mo, Shuyuan; Sypsa, Vana; Guha, Indra Neil; Kumada, Takashi; Niu, Junqi; Dalekos, George; Yasuda, Satoshi; Barnes, Eleanor; Lian, Jianqi; Suri, Vithika; Idilman, Ramazan; Barclay, Stephen T.; Dou, Xiaoguang; Berg, Thomas; Hayes, Peter C.; Flaherty, John F.; Zhou, Yuanping; Zhang, Zhengang; Buti, Maria; Hutchinson, Sharon J.; Guo, Yabing; Calleja, Jose Luis; Lin, Lanjia; Zhao, Longfeng; Chen, Yongpeng; Janssen, Harry L. A.; Zhu, Chaonan; Shi, Lei; Tang, Xiaoping; Gaggar, Anuj; Wei, Lai; Jia, Jidong; Irving, William L.; Johnson, Philip J.; Lampertico, Pietro; Hou, Jinlin |
| 2014 | Amino acid sequence analysis in patients with chronic HCV genotype 1b infection during pegylated interferon-alpha 2a and ribavirin therapy | Fu, Juan-Juan; Kong, Wei-Jing; Jiang, Dong; Pan, Xiu-Cheng; Wei, Lai |
| 2015 | Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection | Deng, Kai; Liu, Ruyu; Rao, Huiying; Jiang, Dong; Wang, Jianghua; Xie, Xingwang; Wei, Lai |
| 2011 | Antiviral activities of ISG20 in positive-strand RNA virus infections | Zhou, Zhi; Wang, Nan; Woodson, Sara E.; Dong, Qingming; Wang, Jie; Liang, Yugiong; Rijnbrand, Rene; Wei, Lai; Nichols, Joan E.; Guo, Ju-Tao; Holbrook, Michael R.; Lemon, Stanley M.; Li, Kui |
| 2019 | APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? | Kanda, Tatsuo; Lau, George K. K.; Wei, Lai; Moriyama, Mitsuhiko; Yu, Ming-Lung; Chuang, Wang-Long; Ibrahim, Alaaeldin; Lesmana, Cosmas Rinaldi Adithya; Sollano, Jose; Kumar, Manoj; Jindal, Ankur; Sharma, Barjesh Chander; Hamid, Saeed S.; Dokmeci, A. Kadir; Mamun-Al-Mahtab; McCaughan, Geofferey W.; Wasim, Jafri; Crawford, Darrell H. G.; Kao, Jia-Horng; Yokosuka, Osamu; Sarin, Shiv Kumar; Omata, Masao |
| 2012 | APASL consensus statements and management algorithms for hepatitis C virus infection | Omata, Masao; Kanda, Tatsuo; Yu, Ming-Lung; Yokosuka, Osamu; Lim, Seng-Gee; Jafri, Wasim; Tateishi, Ryosuke; Hamid, Saeed S.; Chuang, Wan-Long; Chutaputti, Anuchit; Wei, Lai; Sollano, Jose; Sarin, Shiv Kumar; Kao, Jia-Horng; McCaughan, Geoffrey W. |
| 2016 | APASL consensus statements and recommendation on treatment of hepatitis C | Omata, Masao; Kanda, Tatsuo; Wei, Lai; Yu, Ming-Lung; Chuang, Wang-Long; Ibrahim, Alaaeldin; Lesmana, Cosmas Rinaldi Adithya; Sollano, Jose; Kumar, Manoj; Jindal, Ankur; Sharma, Barjesh Chander; Hamid, Saeed S.; Dokmeci, A. Kadir; Mamun-Al-Mahtab; McCaughan, Geofferey W.; Wasim, Jafri; Crawford, Darrell H. G.; Kao, Jia-Horng; Yokosuka, Osamu; Lau, George K. K.; Sarin, Shiv Kumar |
| 2016 | APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing | Omata, Masao; Kanda, Tatsuo; Wei, Lai; Yu, Ming-Lung; Chuang, Wang-Long; Ibrahim, Alaaeldin; Lesmana, Cosmas Rinaldi Adithya; Sollano, Jose; Kumar, Manoj; Jindal, Ankur; Sharma, Barjesh Chander; Hamid, Saeed S.; Dokmeci, A. Kadir; Al-Mahtab, Mamun; McCaughan, Geofferey W.; Wasim, Jafri; Crawford, Darrell H. G.; Kao, Jia-Horng; Yokosuka, Osamu; Lau, George K. K.; Sarin, Shiv Kumar |
